|
1
|
Dezube BJ, Aboulafia DM and Pantanowitz L:
Plasma cell disorders in HIV-infected patients: From benign
gammopathy to multiple myeloma. AIDS Read. 14:372–374, 377-379.
2004.PubMed/NCBI
|
|
2
|
Roodman GD: Mechanisms of bone metastasis.
N Engl J Med. 350:1655–1664. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Longo DL and Anderson KC: Plasma cell
disorders. In: Harrison's principles of internal medicine. Kasper
DL, Braunwald E, Fauci AS, Hauser SL, Longo DL and Jameson JL
(eds). 16th edition. McGraw-Hill, New York, NY, pp657-658,
2005.
|
|
4
|
Van Riet I: Homing mechanisms of myeloma
cells. Pathol Biol (Paris). 47:98–108. 1999.PubMed/NCBI
|
|
5
|
The International Myeloma Working Group:
Criteria for the classification monoclonal gammopathies, multiple
myeloma and related disorders: A report of the international
myeloma working group. Br J Haematol 121: 749-757, 2003.
|
|
6
|
Knobel D, Zouhair A, Tsang RW, Poortmans
P, Belkacémi Y, Bolla M, Oner FD, Landmann C, Castelain B and
Ozsahin M: Rare Cancer Network Prognostic factors in solitary
plasmacytomas of the bone: A multicenter rare cancer network study.
BMC Cancer. 6(118)2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ozsahin M, Tang RW, Poortmans P, Belkacémi
Y, Bolla M, Dinçbas FO, Landmann C, Castelain B, Buijsen J,
Curschmann J, et al: Outcomes and patterns of failure in solitary
plasmacytoma: A multicenter rare cancer network study of 258
patients. Int J Radiat Oncol Biol Phys. 64:210–217. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Micheletti AR, Macedo AC, Silva GB, Silva
AC, Silva-Vergara ML, Murta EF and Adad SJ: Benign and malignant
neoplasias in 261 necropsies for HIV-positive patients in the
period of 1989 to 2008. Rev Inst Med Trop Sao Paulo. 53:309–314.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Diamond T, Levy S, Day P, Barbagallo S,
Manoharan A and Kwan YK: Biochemical, histomorphometric and
densitometric changes in patients with multiple myeloma: Effects of
glucocorticoid therapy and disease activity. Br J Haematol.
97:641–648. 1997.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nilsson-Ehle H, Holmdahl C, Suurküla M and
Westin J: Bone scintigraphy in the diagnosis of skeletal
involvement and metastatic calcification in multiple myeloma. Acta
Med Scand. 211:427–432. 1982.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Terpos E, Berenson J, Cook RJ, Lipton A
and Coleman RE: Prognostic variables for survival and skeletal
complications in patients with multiple myeloma osteolytic bone
disease. Leukemia. 24:1043–1049. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Vincent Rajkumar S: Multiple myeloma: 2014
Update on diagnosis, risk-stratification, and management. Am J
Hematol. 89:999–1009. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Grulich AE, Li Y, McDonald A, Correll PK,
Law MG and Kaldor JM: Rates of non-AIDS-defining cancers in people
with HIV infection before and after AIDS diagnosis. AIDS.
16:1155–1161. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ikezoe T, Saito T, Bandobashi K, Yang Y,
Koeffler HP and Taguchi H: HIV-1 protease inhibitor induces growth
arrest and apoptosis of human multiple myeloma cells via
inactivation of signal transducer and activator of transcription 3
and extracellular signal-regulated kinase 1/2. Mol Cancer Ther.
3:473–479. 2004.PubMed/NCBI
|
|
15
|
Carraway H and Ambinder RF: Plasma cell
dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated
herpesvirus. Curr Opin Oncol. 14:543–545. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Voelkerding KV, Sandhaus LM, Kim HC,
Wilson J, Chittenden T, Levine AJ and Raska K Jr: Plasma cell
malignancy in the acquired immune deficiency syndrome. Association
with Epstein-Barr virus. Am J Clin Pathol. 92:222–228.
1989.PubMed/NCBI View Article : Google Scholar
|
|
17
|
de Camargo Moraes P, Thomaz LA, Montalli
VA, Junqueira JL, Ribeiro CM and Oliveira LB: Extramedullary
plasmacytoma diagnosed in an HIV-positive patient by an unusual
clinical presentation. Case Rep Dent. 2016(6305173)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
De Groot JJB, Webb MJ, Raubenheimer JE,
Struwig MC and Louw VJ: Concomitant HIV infection in newly
diagnosed multiple myeloma patients is hard to recognise and should
be tested for routinely in areas of high endemicity. S Afr Med J.
107:781–787. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cauda R, Lucia MB, Marasca G, Rutella S,
Petrucci MT, La Verde G and Gastaldi R: Beneficial effect of highly
active antiretroviral therapy (HAART) in reducing both HIV viral
load and monoclonal gammopathy. Eur J Haematol. 63:134–135.
1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gimeno LSE, Abella E, Perez-Vila E,
Cervera M, Montero M, Gimenez MT, Knobel H and Besses C: Complete
remission of smoldering myeloma in a HIV patient after highly
antiretroviral therapy. Haematologica. 92 (Suppl 2)(S485)2007.
|
